Protocol & IRB Management

Protocol submission · IRB review · Amendments · Annual review · Trial Master File

CYM-2026-001

Phase II trial of GLP-1 + SGLT-2 combination in T2DM with NAFLD

Dr. Al-Rashid · Phase II

Approved & Active

CYM-2026-002

Randomized comparison of TAVR vs SAVR in intermediate-risk AS

Dr. Al-Ghamdi · Phase III

Approved & Active

CYM-2026-003

Observational registry — Diabetic foot ulcer outcomes in MENA

Dr. Hassan · Observational

Amendment Pending

CYM-2026-004

Pilot — Digital therapeutic for hypertension self-management

Dr. Al-Otaibi · Pilot

IRB Under Review

CYM-2026-005

Pediatric long-COVID symptom prevalence study

Dr. Al-Khalifa · Observational

Draft

Phase II trial of GLP-1 + SGLT-2 combination in T2DM with NAFLD

CYM-2026-001 · Dr. Al-Rashid · Phase II

Enrolled

84 / 120

Sites

3

IRB Approved

2026-02-14

Next Review

2027-02-14

Submission History

Initial IRB Approval2026-02-14
Amendment v1.1 — inclusion criteria2026-04-22
Amendment v1.2 — extension to 30 sites2026-06-10